Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 12 |
NetGPI | no | yes: 0, no: 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0031510 | SUMO activating enzyme complex | 3 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
GO:0140513 | nuclear protein-containing complex | 2 | 1 |
GO:1902494 | catalytic complex | 2 | 1 |
Related structures:
AlphaFold database: A4HG77
Term | Name | Level | Count |
---|---|---|---|
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0016925 | protein sumoylation | 7 | 1 |
GO:0018193 | peptidyl-amino acid modification | 5 | 1 |
GO:0018205 | peptidyl-lysine modification | 6 | 1 |
GO:0019538 | protein metabolic process | 3 | 1 |
GO:0032446 | protein modification by small protein conjugation | 6 | 1 |
GO:0036211 | protein modification process | 4 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0070647 | protein modification by small protein conjugation or removal | 5 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 12 |
GO:0008641 | ubiquitin-like modifier activating enzyme activity | 2 | 12 |
GO:0016874 | ligase activity | 2 | 12 |
GO:0016877 | ligase activity, forming carbon-sulfur bonds | 3 | 12 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 12 |
GO:0140657 | ATP-dependent activity | 1 | 12 |
GO:0019948 | SUMO activating enzyme activity | 3 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 102 | 106 | PF00656 | 0.319 |
CLV_NRD_NRD_1 | 154 | 156 | PF00675 | 0.453 |
CLV_PCSK_KEX2_1 | 154 | 156 | PF00082 | 0.551 |
CLV_PCSK_SKI1_1 | 184 | 188 | PF00082 | 0.366 |
DEG_APCC_DBOX_1 | 212 | 220 | PF00400 | 0.407 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.313 |
DOC_MAPK_gen_1 | 178 | 187 | PF00069 | 0.273 |
DOC_MAPK_MEF2A_6 | 180 | 189 | PF00069 | 0.411 |
DOC_MAPK_MEF2A_6 | 192 | 200 | PF00069 | 0.443 |
DOC_MAPK_MEF2A_6 | 90 | 97 | PF00069 | 0.418 |
DOC_MAPK_NFAT4_5 | 184 | 192 | PF00069 | 0.407 |
DOC_USP7_MATH_1 | 157 | 161 | PF00917 | 0.532 |
DOC_USP7_MATH_1 | 170 | 174 | PF00917 | 0.498 |
LIG_14-3-3_CanoR_1 | 111 | 115 | PF00244 | 0.401 |
LIG_14-3-3_CanoR_1 | 256 | 265 | PF00244 | 0.285 |
LIG_14-3-3_CanoR_1 | 83 | 91 | PF00244 | 0.321 |
LIG_BIR_III_2 | 122 | 126 | PF00653 | 0.463 |
LIG_BRCT_BRCA1_1 | 196 | 200 | PF00533 | 0.467 |
LIG_FHA_1 | 191 | 197 | PF00498 | 0.490 |
LIG_FHA_1 | 40 | 46 | PF00498 | 0.226 |
LIG_FHA_1 | 66 | 72 | PF00498 | 0.395 |
LIG_FHA_2 | 218 | 224 | PF00498 | 0.409 |
LIG_FHA_2 | 60 | 66 | PF00498 | 0.395 |
LIG_FHA_2 | 94 | 100 | PF00498 | 0.431 |
LIG_GBD_Chelix_1 | 148 | 156 | PF00786 | 0.460 |
LIG_IBAR_NPY_1 | 92 | 94 | PF08397 | 0.189 |
LIG_LIR_Gen_1 | 269 | 274 | PF02991 | 0.423 |
LIG_LIR_Gen_1 | 96 | 104 | PF02991 | 0.426 |
LIG_LIR_Nem_3 | 163 | 168 | PF02991 | 0.453 |
LIG_LIR_Nem_3 | 96 | 101 | PF02991 | 0.426 |
LIG_PDZ_Class_2 | 282 | 287 | PF00595 | 0.457 |
LIG_SH2_CRK | 153 | 157 | PF00017 | 0.505 |
LIG_SH2_CRK | 182 | 186 | PF00017 | 0.367 |
LIG_SH2_CRK | 98 | 102 | PF00017 | 0.341 |
LIG_SH2_NCK_1 | 208 | 212 | PF00017 | 0.428 |
LIG_SH2_NCK_1 | 98 | 102 | PF00017 | 0.341 |
LIG_SH2_PTP2 | 94 | 97 | PF00017 | 0.189 |
LIG_SH2_STAP1 | 9 | 13 | PF00017 | 0.273 |
LIG_SH2_STAT3 | 70 | 73 | PF00017 | 0.341 |
LIG_SH2_STAT3 | 9 | 12 | PF00017 | 0.285 |
LIG_SH2_STAT5 | 70 | 73 | PF00017 | 0.432 |
LIG_SH2_STAT5 | 94 | 97 | PF00017 | 0.189 |
LIG_SH3_3 | 166 | 172 | PF00018 | 0.487 |
LIG_TYR_ITSM | 94 | 101 | PF00017 | 0.195 |
MOD_CK2_1 | 157 | 163 | PF00069 | 0.446 |
MOD_GlcNHglycan | 107 | 110 | PF01048 | 0.535 |
MOD_GlcNHglycan | 236 | 239 | PF01048 | 0.548 |
MOD_GlcNHglycan | 258 | 261 | PF01048 | 0.338 |
MOD_GlcNHglycan | 85 | 88 | PF01048 | 0.385 |
MOD_GSK3_1 | 139 | 146 | PF00069 | 0.413 |
MOD_GSK3_1 | 190 | 197 | PF00069 | 0.498 |
MOD_NEK2_1 | 104 | 109 | PF00069 | 0.526 |
MOD_NEK2_1 | 139 | 144 | PF00069 | 0.399 |
MOD_NEK2_1 | 25 | 30 | PF00069 | 0.337 |
MOD_NEK2_2 | 93 | 98 | PF00069 | 0.341 |
MOD_PIKK_1 | 17 | 23 | PF00454 | 0.278 |
MOD_PKA_2 | 110 | 116 | PF00069 | 0.413 |
MOD_Plk_4 | 143 | 149 | PF00069 | 0.401 |
MOD_Plk_4 | 170 | 176 | PF00069 | 0.430 |
MOD_Plk_4 | 93 | 99 | PF00069 | 0.420 |
TRG_DiLeu_BaEn_1 | 280 | 285 | PF01217 | 0.437 |
TRG_ENDOCYTIC_2 | 153 | 156 | PF00928 | 0.485 |
TRG_ENDOCYTIC_2 | 182 | 185 | PF00928 | 0.368 |
TRG_ENDOCYTIC_2 | 208 | 211 | PF00928 | 0.442 |
TRG_ENDOCYTIC_2 | 270 | 273 | PF00928 | 0.380 |
TRG_ENDOCYTIC_2 | 94 | 97 | PF00928 | 0.299 |
TRG_ENDOCYTIC_2 | 98 | 101 | PF00928 | 0.329 |
TRG_ER_diArg_1 | 153 | 155 | PF00400 | 0.537 |
TRG_Pf-PMV_PEXEL_1 | 159 | 163 | PF00026 | 0.466 |
TRG_Pf-PMV_PEXEL_1 | 166 | 171 | PF00026 | 0.421 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P2G3 | Leptomonas seymouri | 54% | 100% |
A0A0S4IP88 | Bodo saltans | 26% | 82% |
A0A1X0NVF2 | Trypanosomatidae | 31% | 97% |
A0A3S7X162 | Leishmania donovani | 88% | 100% |
A0A422N6R9 | Trypanosoma rangeli | 34% | 98% |
A4HKL5 | Leishmania braziliensis | 100% | 100% |
A4I3A8 | Leishmania infantum | 88% | 100% |
D0A7U0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 33% | 97% |
E9AZJ7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 100% |
Q4Q8N4 | Leishmania major | 86% | 100% |
V5DAI2 | Trypanosoma cruzi | 39% | 98% |